Combined PRP and hyaluronic acid injections for knee osteoarthritis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study at CHU Amiens evaluates the real-world use of combined intra-articular injections of platelet-rich plasma (PRP) and hyaluronic acid (HA) for knee osteoarthritis. It aims to observe outcomes after one year of treatment in adults already receiving viscosupplementation or PRP-HA injections. The protocol acknowledges variability in PRP preparation and injection practices and seeks to understand effectiveness across these common clinical approaches. No randomized comparisons are described, focusing on real-world experience and patient responses. Eligibility includes adults undergoing knee OA treatment with PRP-HA or HA alone, with data consent and language considerations noted.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* age : \> 18 years old
* Patients benefiting, in the context of knee osteoarthritis, from viscosupplementation alone or from two injections of PRP, in combination with HA, at the Amiens University Hospital.

Exclusion Criteria:

* Patient refusal to use the data
* Language barrier
* Age less than 18 years old.

Where it's running

• CHU Amiens
  Amiens, France Recruiting

Study contacts

• Study coordinator: Laure Le Monnier, Md
• Email: lemonnier.laure@chu-amiens.fr
• Phone: 03 22 66 82 50

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Botulinum toxin vs hyaluronic acid injections for knee osteoarthritis

  This study tests whether injecting botulinum toxin or hyaluronic acid directly into the knee provides better pain relief for people with knee osteoarthritis.

  Recruiting Tanta University · Tanta, El-Gharbia · NCT07666347

• Hyaluronic acid injections to reduce knee inflammation and improve symptoms

  This trial will see if hyaluronic acid knee injections lower inflammatory markers (TNF‑alpha and IL‑1β) and improve pain, function, and quality of life in adults 45–75 with moderate (Kellgren‑Lawrence 2–3) knee osteoarthritis.

  Recruiting Istanbul University · Istanbul · NCT06960564

• Effects of virtual reality on walking in adults with knee osteoarthritis

  This study tests how immersive virtual reality environments—designed to feel safe or to provoke fear—affect walking and worry about movement in adults 50 and older with knee osteoarthritis and in healthy peers.

  Recruiting University of Primorska · Vilnius and 1 other locations · NCT07920120

• Improved Facial Skin Quality After VYC-12L for Breast Cancer Survivors

  This study tests whether intradermal injections of VYC-12L can improve facial skin quality and quality of life in adults who have completed breast cancer treatment.

  Recruiting Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia · Murcia, Murcia · NCT07917117

• Weekly berobenatide for knee osteoarthritis in adults who are overweight or obese

  This study tests whether weekly berobenatide helps reduce knee pain and improve function, while also affecting body weight, in adults with knee osteoarthritis who are overweight or obese (with or without type 2 diabetes).

  Recruiting Phase 3 Pfizer · Birmingham, Alabama and 3 other locations · NCT07915609

• Autologous adipose-derived stem cell injections for knee osteoarthritis

  We’re testing whether injecting a patient’s own fat-derived stem cells into the knee can help people with knee OA feel less pain and move better, compared with a standard hyaluronic acid treatment.

  Recruiting at 3 sites Yonsei University · Incheon and 2 other locations · NCT07901790

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.